Evidence-Based Treatments for Adults with Migraine

Area of Science:

• Neurology
• Pain Management
• Medical Devices

Background:

• Migraine is a disabling neurological disorder impacting millions globally.
• Current acute and preventive treatments offer limited efficacy for a subset of patients.
• Many existing migraine drugs lack specificity and were repurposed from other conditions.

Purpose of the Study:

• To review the evidence for current and emerging migraine treatments.
• To highlight the need for migraine-specific therapeutic agents.
• To evaluate the potential of noninvasive neuromodulation as a novel migraine therapy.

Main Methods:

• Systematic review of existing literature on migraine pharmacotherapy.
• Analysis of clinical trial data for noninvasive neuromodulation devices.
• Evidence-based assessment of treatment efficacy and tolerability.

Main Results:

• Standard migraine medications provide modest benefits and are often not migraine-specific.
• Alternative therapies lack robust supporting evidence.
• Noninvasive neuromodulation presents a promising, well-tolerated treatment option with growing evidence.

Conclusions:

• There is a significant unmet need for more effective and specific migraine treatments.
• Noninvasive neuromodulation represents a key advancement in migraine management.
• Further research is warranted to optimize neuromodulation techniques for diverse patient populations.